J Pain Symptom Manage. 2015;49(6):1050-1058.e2.
Differences in Performance Status Assessment Among Palliative Care Specialists, Nurses, and Medical Oncologists.
제1저자 김유정 · 교신저자 Eduardo Bruera
소속 (6)
- Department of Palliative Care and Rehabilitation Medicine, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA; Division of Hematology and Medical Oncology, Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea.
- Department of Palliative Care and Rehabilitation Medicine, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA.
- Department of Palliative Care and Rehabilitation Medicine, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA; Department of Medical Oncology, Shanghai University of Traditional Chinese Medicine, Shuguang Hospital, Shanghai, China.
- Department of Palliative Care and Rehabilitation Medicine, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA; Division of Hematology-Oncology, Department of Internal Medicine, Daejeon St. Mary's Hospital, The Catholic University of Korea, Daejeon, Republic of Korea.
- Department of Biostatistics, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA.
- Department of Palliative Care and Rehabilitation Medicine, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA. Electronic address: ebruera@mdanderson.org.
Abstract
CONTEXT The Eastern Cooperative Oncology Group performance status (ECOG PS) is one of the most commonly used assessments in oncology and palliative care (PC). However, the interobserver differences between medical oncologists and PC specialists have never been reported.
OBJECTIVES To determine the interobserver differences in ECOG PS assessment among PC specialists, PC nurses, and medical oncologists in patients with advanced cancer.
METHODS We retrospectively reviewed the medical records of all patients who had an outpatient PC consultation in 2013 and identified 278 eligible patients. We retrieved the ECOG PS scores and symptom burden assessed by the Edmonton Symptom Assessment System (ESAS).
RESULTS PC specialists (median +0.5, P < 0.0001) and nurses (median +1.0, P < 0.0001) rated the ECOG PS significantly higher than medical oncologists. The weighted kappa values were 0.26 between PC specialists and medical oncologists and 0.61 between PC specialists and nurses. PC specialists' assessments correlated with ESAS fatigue, dyspnea, anorexia, feeling of well-being, and symptom distress score. The ECOG PS assessments by all three groups were significantly associated with survival (P < 0.001). However, patients with ECOG PS 2 and 3-4 rated by their medical oncologists had similar survival (P = 0.67). Predictors of discordance in ECOG PS assessments between PC specialists and medical oncologists were the presence of a potentially effective treatment (odds ratio [OR] 2.39; 95% CI 1.09-5.23) and poor feeling of well-being (≥4) (OR 2.38, 95% CI 1.34-4.21).
CONCLUSION ECOG PS assessments by PC specialists and nurses were significantly higher than those of medical oncologists. Systematic efforts to increase regular interdisciplinary communications may help to bridge this gap.
Copyright © 2015 American Academy of Hospice and Palliative Medicine. Published by Elsevier Inc. All rights reserved.
Keywords
ECOG performance statusadvanced cancermedical oncologistnursepalliative care specialist
그 밖의 정보
- 출판 형태
- Comparative Study, Journal Article, Research Support, N.I.H., Extramural
- 저널
- Journal of pain and symptom management · eISSN 1873-6513
- 전자 출판
- 2014-12-24
- MeSH
- Adult · Aged · Aged, 80 and over · Female · Hospice and Palliative Care Nursing* · Humans · Kaplan-Meier Estimate · Male · Medical Oncology* · Middle Aged · Multivariate Analysis · Neoplasms / diagnosis · Observer Variation · Palliative Care* · Palliative Medicine* · Retrospective Studies · Severity of Illness Index · Young Adult
- 연구비
- NCI NIH HHS R01CA122292-01 · NCI NIH HHS R01 CA122292 · NINR NIH HHS R01 NR010162 · NCI NIH HHS R01CA124481-01 · NINR NIH HHS R01NR010162-01A1 · NCI NIH HHS R01 CA124481